Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 891972, 7 pages
http://dx.doi.org/10.1155/2015/891972
Research Article

Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status

1Laboratorio de Biología Molecular, Unidad de Investigación Médica en Nutrición, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, 4th Floor, Avenida Cuauhtémoc No. 330, Colonia Doctores, Delegación Cuauhtémoc, 06725 México, DF, Mexico
2Servicio de Electrodiagnóstico y Distrofia Muscular, Instituto Nacional de la Rehabilitación, México, DF, Mexico

Received 2 February 2015; Revised 18 March 2015; Accepted 27 March 2015

Academic Editor: Akanchha Kesari

Copyright © 2015 Oriana del Rocío Cruz-Guzmán et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Straub and K. P. Campbell, “Muscular dystrophies and the dystrophin-glycoprotein complex,” Current Opinion in Neurology, vol. 10, no. 2, pp. 168–175, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. M. W. Berchtold, H. Brinkmeier, and M. Müntener, “Calcium ion in skeletal muscle: Its crucial role for muscle function, plasticity, and disease,” Physiological Reviews, vol. 80, no. 3, pp. 1215–1265, 2000. View at Google Scholar · View at Scopus
  3. B. De Paepe and J. L. De Bleecker, “Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy,” Mediators of Inflammation, vol. 2013, Article ID 540370, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Saito, D. Kobayashi, M. Komatsu et al., “A sensitive assay of tumor necrosis factor α in sera from Duchenne muscular dystrophy patients,” Clinical Chemistry, vol. 46, no. 10, pp. 1703–1704, 2000. View at Google Scholar · View at Scopus
  5. N. P. Evans, S. A. Misyak, J. L. Robertson, J. Bassaganya-Riera, and R. W. Grange, “Immune-mediated mechanisms potentially regulate the disease time-course of Duchenne muscular dystrophy and provide targets for therapeutic intervention,” PM & R, vol. 1, no. 8, pp. 755–768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. de Pasquale, A. D'Amico, M. Verardo, S. Petrini, E. Bertini, and F. de Benedetti, “Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy,” Neurology, vol. 78, no. 17, pp. 1309–1314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Rufo, A. del Fattore, M. Capulli et al., “Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans,” Journal of Bone and Mineral Research, vol. 26, no. 8, pp. 1891–1903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Scott and S. J. Mawson, “Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool,” Developmental Medicine & Child Neurology, vol. 48, no. 6, pp. 540–544, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. V. D. Nadarajah, M. van Putten, A. Chaouch et al., “Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD),” Neuromuscular Disorders, vol. 21, no. 8, pp. 569–578, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Deconinck and B. Dan, “Pathophysiology of Duchenne muscular dystrophy: current hypotheses,” Pediatric Neurology, vol. 36, no. 1, pp. 1–7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. E. Davidson, M. M. Ryan, A. J. Kornberg et al., “Observations of body mass index in Duchenne muscular dystrophy: a longitudinal study,” European Journal of Clinical Nutrition, vol. 68, no. 8, pp. 892–897, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Rodríguez-Cruz, R. Sanchez, R. E. Escobar et al., “Evidence of insulin resistance and other metabolic alterations in boys with Duchenne or Becker muscular dystrophy,” International Journal of Endocrinology. In press.
  13. H. S. Park, J. Y. Park, and R. Yu, “Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6,” Diabetes Research and Clinical Practice, vol. 69, no. 1, pp. 29–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-S. Moon, D.-H. Kim, and D.-K. Song, “Serum tumor necrosis factor-α levels and components of the metabolic syndrome in obese adolescents,” Metabolism: Clinical and Experimental, vol. 53, no. 7, pp. 863–867, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. J. Schwarzenberg and A. R. Sinaiko, “Obesity and inflammation in children,” Paediatric Respiratory Reviews, vol. 7, no. 4, pp. 239–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. M. Shamsuzzaman, M. Winnicki, R. Wolk et al., “Independent association between plasma leptin and C-reactive protein in healthy humans,” Circulation, vol. 109, no. 18, pp. 2181–2185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Aeberli, L. Molinari, G. Spinas, R. Lehmann, D. l'Allemand, and M. B. Zimmermann, “Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children,” The American Journal of Clinical Nutrition, vol. 84, no. 4, pp. 748–755, 2006. View at Google Scholar · View at Scopus
  18. I. Abdel-Megui, E. Abdel-Salam, and S. Korraa, “Cytokines and growth factors in Duchene muscular dystrophy patients,” Egyptian Journal of Medical Human Genetics, vol. 9, no. 2, pp. 181–188, 2009. View at Google Scholar
  19. P. J. Vignos Jr., G. E. Spencer Jr., and K. C. Archibald, “Management of progressive muscular dystrophy in childhood,” The Journal of the American Medical Association, vol. 184, no. 2, pp. 89–96, 1963. View at Google Scholar · View at Scopus
  20. P. M. Stevens, “Lower limb orthotic management of Duchenne muscular dystrophy: a literature review,” Journal of Prosthetics and Orthotics, vol. 18, no. 4, pp. 111–119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Zatz, M. Vainzof, and M. R. Passos-Bueno, “Serum creatine kinase in progressive muscular dystrophies,” in Muscular Dystrophy, vol. 43 of Methods in Molecular Medicine, pp. 31–49, Springer, New York, NY, USA, 2001. View at Publisher · View at Google Scholar
  22. A. E. Emery and F. Muntoni, Duchenne Muscular Dystrophy, vol. 24, Oxford University Press, New York, NY, USA, 1993.
  23. K. Arahata and A. G. Engel, “Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells,” Annals of Neurology, vol. 16, no. 2, pp. 193–208, 1984. View at Publisher · View at Google Scholar · View at Scopus
  24. A. G. Engel and K. Arahata, “Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies,” Human Pathology, vol. 17, no. 7, pp. 704–721, 1986. View at Publisher · View at Google Scholar · View at Scopus
  25. J. R. M. Gorospe, M. D. Tharp, J. Hinckley, J. N. Kornegay, and E. P. Hoffman, “A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice,” Journal of the Neurological Sciences, vol. 122, no. 1, pp. 44–56, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. S. S. Welc and T. L. Clanton, “The regulation of interleukin-6 implicates skeletal muscle as an integrative stress sensor and endocrine organ,” Experimental Physiology, vol. 98, no. 2, pp. 359–371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Peake, P. della Gatta, K. Suzuki, and D. Nieman, “Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects,” Exercise Immunology Review, vol. 21, pp. 8–25, 2015. View at Google Scholar
  28. A. Henriques-Pons, Q. Yu, S. Rayavarapu et al., “Role of toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle,” Human Molecular Genetics, vol. 23, no. 10, pp. 2604–2617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. B. K. McFarlin, C. A. Johnston, C. Tyler et al., “Inflammatory markers are elevated in overweight Mexican-American children,” International Journal of Pediatric Obesity, vol. 2, no. 4, pp. 235–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Anty, S. Bekri, N. Luciani et al., “The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH,” The American Journal of Gastroenterology, vol. 101, no. 8, pp. 1824–1833, 2006. View at Publisher · View at Google Scholar · View at Scopus